How to Start a Travel Agency in India: A Proven Guide for 2025

Understanding Company Capital Structure in 2025

Authorized capital is the maximum amount of share capital that a company is authorized to issue, while Paid-Up Capital is the actual amount of share capital issued and paid for by shareholders.

A company's capital structure forms the bedrock of its financial framework. This structure shows how a business funds its operations by mixing equity and debt to create a roadmap for growth and stability.

What is authorized capital and how is it defined in MOA?

Authorized capital (also called nominal or registered capital) sets the maximum share capital a company can legally issue to shareholders. The company's Memorandum of Association (MOA) clearly defines this limit under the Capital Clause.

This capital acts as a regulatory boundary. A private limited company with an authorized capital of ₹10 lakh can't issue more shares beyond this amount unless it changes its MOA. The company needs shareholder approval for this change and must file it with the Registrar of Companies within thirty days.

Paid-up capital meaning and its role in equity funding

Paid-up capital is the actual money shareholders give to a company when they buy shares. Unlike authorized capital, this represents real money in the company's accounts that it can use for business operations.

The 2015 Companies Act amendment removed the minimum paid-up capital requirement. Now entrepreneurs can start with just ₹5,000. This money proves valuable because you don't need to pay it back like a loan. The paid-up capital also shows the company's financial health, how much it relies on equity, and its loan repayment capacity.

Why capital structure matters during company registration

A well-laid-out capital structure shapes a new company's operations and growth potential. Your company's capital structure during registration affects:

1. Financial flexibility - A smart capital structure lets you raise future funds without changing legal documents often.
   
2. Risk assessment - Investors and lenders look at your capital structure to check financial stability.
   
3. Registration costs - Your authorized capital amount decides the registration fees and stamp duty.
   

Companies should balance their original capital structure based on what their industry needs, how they plan to grow, and where they can get funding.

Authorized Capital vs Paid-Up Capital: Key Differences

Understanding the distinction between authorized capital and paid-up capital is fundamental to grasping a company's capital structure. This knowledge is crucial for effective corporate governance, regulatory compliance, and financial planning.

Legal Definitions and Compliance Framework

• Authorized Capital is the maximum share capital a company is legally permitted to issue, as specified in its Memorandum of Association (MoA). This acts as a ceiling, ensuring that the company cannot issue shares beyond this limit without amending its foundational documents.
  
• Paid-Up Capital is the actual amount of money received from shareholders in exchange for shares issued. By law, paid-up capital must always be less than or equal to authorized capital.
  

Impact on Share Issuance and Fundraising

• Authorized capital represents the company’s potential for raising funds, setting the upper boundary for share issuance. It provides flexibility for future fundraising and expansion without the need for immediate regulatory changes.
  
• Paid-up capital reflects the real investment made by shareholders and is the actual capital available for business operations. It is recorded in the company’s financial statements and directly impacts the company’s financial strength and investor confidence.
  

When a company reaches its authorized capital limit with paid-up capital, it faces two choices:

• Increase authorized capital through a formal amendment to the MoA, requiring shareholder approval and regulatory filings.
  
• Facilitate share transfers among existing and new shareholders, without increasing the total capital.
  

Capital Flexibility: Changes and Procedures

• Authorized Capital: Can be increased or decreased by amending the MoA, which involves:
  
  • Reviewing the Articles of Association (AoA) for relevant provisions.
    
  • Passing a board resolution to convene a shareholders' meeting.
    
  • Obtaining shareholder approval via an ordinary or special resolution.
    
  • Filing statutory forms (such as eForm SH-7 and eForm MGT-14) with the Registrar of Companies within the prescribed timeframe.
    
• Paid-Up Capital: Changes only when the company issues new shares or when existing shares are fully paid up. This directly affects the company’s liability for dividends and its operational capital.
  

Comparative Table: Authorized Capital vs Paid-Up Capital

How to Decide Capital Amounts for New Companies

You need a well-laid-out approach to calculate the right capital amounts for your new company. This helps balance your current needs with future growth. Here's how you can break this down into four practical steps:

Step 1: Estimate operational and contingency needs

Start with a financing plan that shows your startup costs. Your plan should cover equipment purchases, premises costs, inventory, and working capital needs for your first 6-12 months. You'll need enough buffer money to handle unexpected expenses that could disrupt your operations. Capital projects always face uncertainties, so you should set aside a contingency fund—about 30% of your total estimated needs—to maintain financial stability. This fund serves as your safety net against future uncertainties.

Step 2: Set authorized capital for future scalability

After you figure out your requirements, you should set your authorized capital at 5-10 times your original paid-up capital. This gives you room to raise funds later without changing your MOA. To cite an instance, see how a ₹2 lakh immediate paid-up capital works better with ₹10-20 lakh authorized capital to create flexibility. Keep in mind that authorized capital sets your fundraising limit but doesn't represent actual money you can use.

Step 3: Determine paid-up capital based on shareholder commitment

Your shareholders' realistic contribution becomes your paid-up capital—the actual money invested in your company. Most startups work well with paid-up capital between ₹1 lakh and ₹5 lakh, based on what their industry needs. The final amount should match both your immediate operational needs and your shareholders' risk appetite.

Step 4: Consider ROC fees and stamp duty implications

The regulatory costs change with different capital amounts. ROC filing fees increase as your authorized capital grows—from ₹4,000 for capital under ₹1 lakh to ₹1,56,000 plus extra fees when capital exceeds ₹1 crore. The stamp duty (usually 0.15% of authorized capital) applies when you register or increase capital. A 2021 Supreme Court ruling made this duty a one-time payment with a maximum cap, whatever the future capital increases might be.

Case Study: Capital Planning for ABC Pvt Ltd

Let's get into how ABC Pvt Ltd planned its capital structure to balance current costs with future growth needs.

Original capital structure: ₹10 lakh authorized, ₹1 lakh paid-up

ABC Pvt Ltd set up its capital framework with ₹10 lakh authorized capital against ₹1 lakh paid-up capital. The company followed the post-2015 Companies Act amendment that removed the minimum paid-up capital requirement. This 10:1 ratio creates a perfect balance. It gives enough operational funds through actual investment while leaving room for future growth without needing regulatory changes.

ROC fee effects based on capital tiers

The company thought about how fees work at different capital levels. ABC Pvt Ltd kept its authorized capital at ₹10 lakh to avoid higher fee brackets. The ROC fee stays around ₹35,000 plus extra charges for authorized capital under ₹10 lakh. The company would pay much more if they go beyond this limit - ₹1,35,000 plus ₹100 per ₹10,000 for capital between ₹50 lakh and ₹1 crore.

Flexibility for future share issuance without MOA change

ABC Pvt Ltd can issue extra shares worth ₹9 lakh without changing its MOA. This difference between authorized and current paid-up capital gives them room to grow. Going beyond the ₹10 lakh mark would need shareholder approval, a board resolution, an extraordinary general meeting, and filing Form SH-7 with the Registrar within thirty days.

Cost-benefit analysis of higher authorized capital

The company's capital planning shows smart financial thinking. The ₹10 lakh authorized capital balances several factors:

Current savings: Lower ROC fees and stamp duty (usually 0.15% of authorized capital) Future flexibility: Room to issue extra shares worth ₹9 lakh without paperwork Credibility advantage: Better stability in the eyes of potential investors and partners

ABC Pvt Ltd shows how smart capital planning helps long-term business goals while keeping initial registration costs low. This matters a lot for new companies with tight budgets.

Frequently Asked Questions

About the Pharma Company in India

A pharmaceutical company is an entity involved in the development, manufacturing, distribution, and marketing of medicines and healthcare products. Depending on the business model, pharma companies in India are typically classified as:

• Manufacturing companies: involved in the production of drugs and medicines.
• Marketing companies: focus on branding and distribution, often outsourcing manufacturing.
• Wholesale businesses: supply medicines in bulk to retailers, hospitals, and distributors.
• Retail businesses: run pharmacies and directly sell medicines to consumers.

India’s pharmaceutical industry has been expanding rapidly. As of 2025, it is valued at $55 billion and is projected to reach $120–130 billion by 2030. The government has also introduced several supportive measures:

• 100% Foreign Direct Investment (FDI) allowed in greenfield pharma projects.
• ₹15,000 crore PLI (Production Linked Incentive) scheme to promote domestic manufacturing.
• Incentives for Active Pharmaceutical Ingredients (APIs) and medical devices to reduce import dependency.

With this growth potential, starting a pharmaceutical business in India is both a profitable and impactful opportunity.

Choosing the Right Business Structure for a Pharma Company

The first step in starting a pharmaceutical business in India is selecting the proper business structure. The choice depends on the scale of operations, funding requirements, and ownership preferences. Common structures include:

• Limited Liability Partnership (LLP): Offers flexibility with limited liability.
  Private Limited Company (Pvt Ltd): Ideal for manufacturing and marketing businesses due to scalability and investor appeal.
• Public Limited Company: Suitable for large-scale operations planning to raise funds from the public.
• Indian Subsidiary of a Foreign Company: Allows foreign companies to establish a presence in India and leverage the growing market.

India ranks 3rd in the world by volume and 14th by value in pharmaceuticals, making it a preferred hub for domestic and international players. Choosing the right structure ensures smooth registration and compliance.

Eligibility for Registering a Pharma Company

Eligibility criteria are designed to maintain quality and compliance in the pharma sector. Key rules include:

• The applicant must be legally competent to enter into a contract.
• The company must appoint qualified directors and pharmacists, depending on the business type.
• Proper compliance with the Drugs and Cosmetics Act of 1940 is mandatory.
• Only individuals or entities with relevant pharmaceutical qualifications/experience can run such businesses.

Requirements for Registering a Pharma Company

Corporate & Structural Requirements

These are the standard legal requirements for forming a company under the Ministry of Corporate Affairs (MCA).

• Directors and Members: The structure depends on your company type. For a Private Limited Company, a minimum of two directors and two members (shareholders) are required. The same individuals can hold both positions.
• Director Credentials: Every proposed director must have a Digital Signature Certificate (DSC) for online document submission and a Director Identification Number (DIN), a unique identifier issued by the MCA.
• Unique Company Name: Your proposed company name must be unique and not resemble any existing company or trademark. It must be approved and reserved through the MCA portal.
• Registered Office Address: You must provide a physical address in India as the company's official registered office. Proof of address, such as a utility bill or rental agreement, is mandatory for verification.

Pharmaceutical & Technical Requirements

These are specific mandates from the Drugs and Cosmetics Act, 1940, enforced by state drug control departments, which are essential for obtaining a drug license.

Qualified Technical Personnel: 

You must employ qualified individuals to supervise the sale and distribution of drugs. The requirements vary based on the business type:

• For Wholesale Business (Distribution): The operations must be supervised by a "Competent Person." This can be:
  
  • A Registered Pharmacist.
  • A graduate with at least one year of experience in dealing with drugs.
• For Retail Business (Pharmacy): All sales and dispensing activities must be conducted under the direct supervision of a Registered Pharmacist.

Adequate Storage Premises: 

You must have a proper commercial space for storing medicines. The premises are inspected by a Drug Inspector and must meet specific conditions:

• Minimum Area: Typically, a minimum of 10 square meters is required for a wholesale license. This can vary by state.
• Proper Storage Facilities: The premises must be clean, well-lit, and equipped with necessary storage solutions like cupboards, racks, and, crucially, a refrigerator and freezer to store temperature-sensitive drugs like vaccines and serums.

Enjoy limited liability protection, easy fundraising, and better brand credibility. Register your Pvt Ltd company online with Razorpay Rize and focus on building your pharmaceutical business while we handle compliance.

‍

How to Start a Pharmaceutical Company in India?

The incorporation process is now simplified through the SPICe+ (Simplified Proforma for Incorporating a Company Electronically Plus) form by the Ministry of Corporate Affairs. Steps include:

Phase 1: Business Incorporation

The first step is to register your business as a legal entity with the Ministry of Corporate Affairs (MCA). The modern SPICe+ (Simplified Proforma for Incorporating a Company Electronically Plus) form has streamlined this process significantly.

• Get Director Credentials: All proposed directors of the company must obtain a Digital Signature Certificate (DSC) and a Director Identification Number (DIN). The DSC is an electronic signature used for filing documents online, and the DIN is a unique number assigned to each director.
• Reserve a Company Name: You must apply for and reserve a unique name for your company. This can be done through the MCA portal's RUN (Reserve Unique Name) service or directly within the SPICe+ form.
• Draft Foundational Documents: Two critical documents need to be prepared:
  
  • Memorandum of Association (MoA): This document defines the company's objectives and the scope of its business activities.
  • Articles of Association (AoA): This document outlines the internal rules and regulations for managing the company.
• File the SPICe+ Form: This single, integrated web form is used to file for incorporation. It combines applications for the company name, DIN allotment, and issuance of important tax numbers like PAN and TAN.
• Receive Certificate of Incorporation: Once the MCA approves your application, you will receive a Certificate of Incorporation. This certificate includes your unique Corporate Identity Number (CIN) and officially marks the legal birth of your company.

Phase 2: Securing Pharmaceutical Licenses

This is the most critical phase and is specific to the pharmaceutical industry. These licenses are granted by the Central Drugs Standard Control Organization (CDSCO) and State Drug Control Departments.

• Drug License: This is the primary license required to deal with drugs and cosmetics. The type of license depends on your business model:
  
  • Manufacturing License: Required if you plan to manufacture drugs. This involves a rigorous inspection of your manufacturing facility to ensure it complies with Good Manufacturing Practices (GMP) and has the necessary technical staff and equipment.
  • Wholesale/Distribution License: Required for stocking, selling, and distributing drugs. This requires having adequate storage premises with proper refrigeration facilities and employing a registered pharmacist.
• GST Registration: Before you can apply for a drug license, you must complete your Goods and Services Tax (GST) registration. The GSTIN is a mandatory requirement for the drug license application.

‍

Phase 3: Brand and Tax Formalities

With your company and licenses in place, the final step is to protect your brand and manage your finances.

• Trademark Registration: It is highly advisable to register your company name, logo, and the brand names of your pharmaceutical products. This protects your intellectual property and prevents others from using similar names.
• Bank Account Opening: You can open a corporate bank account using the Certificate of Incorporation and other registration documents.

‍

Get started with Razorpay Rize and complete your company registration online in just a few clicks. Fast approvals, 100% digital process, and expert support to make your pharma business official.

Documents Required to Register a Pharma Company

Here’s a checklist of essential documents required to open pharma company:

For Indian Directors/Shareholders:

• PAN Card
• Aadhaar Card
• Passport-size photographs
• Address proof (utility bill, bank statement)

For Foreign Directors/Shareholders:

• Passport (notarised and apostilled)
• Proof of overseas address
• Photograph

For the Company:

• Registered office address proof (rent agreement/ownership proof)
• Utility bill of the premises (electricity/water bill)
• MoA and AoA

Other Registrations Required for a Pharma Company

After incorporation, a pharma company must obtain additional registrations and licenses to operate legally:

1. Drug License (under the Drugs and Cosmetics Act, 1940)
   
   
   
   • Manufacturing License
   • Wholesale License
   • Retail License
   • Loan License (for outsourcing manufacturing)
   • Import License (for foreign medicines)
     
     
2. GST Registration – Mandatory for taxation and interstate sales.
3. FSSAI Registration – Required if dealing with nutraceuticals or dietary supplements.
4. Trademark & Patent Registration – Protects brand identity and intellectual property.
5. Import Export Code (IEC) – For companies engaged in pharma exports/imports.

Frequently Asked Questions (FAQs)

Defining Oppression and Mismanagement

The Companies Act, 2013, does not explicitly define oppression and mismanagement. Instead, their meanings have evolved through judicial interpretations and case law.

In simple terms:

• Oppression involves burdensome, harsh, or wrongful conduct toward minority shareholders. It typically refers to situations where the majority shareholders abuse their power to harm the minority's rights or interests.
  
  
• Mismanagement refers to gross mismanagement of company affairs, which could lead to financial loss or harm to the company’s reputation or operations. It often involves negligence, fraud, or actions taken in bad faith by those in control.

Legal Remedies under Sections 241–246

Sections 241 to 246 of the Companies Act, 2013 empower company members to approach the National Company Law Tribunal (NCLT) if they believe the company’s affairs are being conducted in a manner that amounts to oppression or mismanagement.

If the tribunal is satisfied, it can order remedies such as:

• Regulation of the company’s future conduct
• Removal of directors
• Termination, modification, or setting aside of certain agreements
• Recovery of misappropriated funds
• Preventive actions to safeguard the company’s interests

A Detailed Explanation of Section 241

Section 241 of the Companies Act, 2013 is the core provision that allows members to seek relief from oppression and mismanagement.

Section 241 exists to protect minority shareholders and the company itself from conduct that threatens their interests. It ensures that no shareholder or director misuses their powers to the detriment of others or the company.

Under Section 241, a member can apply to the NCLT if:

• The company’s affairs are being conducted in a manner oppressive to any member(s).
• There has been mismanagement that threatens to cause serious prejudice to the interests of the company, members, or the public.

How can an Application be made under Section 241?

Filing an application under Section 241 involves a specific legal process:

Who Can Apply?

Eligible members include:

• Shareholders holding at least 10% of the company’s issued share capital
• In companies without share capital, at least 1/5th of the total number of members
  In certain cases, members may request NCLT permission to file even if they do not meet the above thresholds (especially where the majority is acting in bad faith).

Grounds for Filing

The application must clearly describe:

• Acts of oppression (specific conduct harming member rights)
• Acts of mismanagement (negligence, fraud, misconduct, etc.)
• Resulting harm to the company or its members

Documentation Required

• Petition/application under Section 241
• Evidence of shareholding or membership eligibility
• Documentary proof of oppressive/mismanaged conduct
• Affidavit verifying the facts
• Court fees as prescribed

Where to File?

Applications must be filed with the relevant bench of the National Company Law Tribunal (NCLT) having jurisdiction over the company’s registered office.

{{company-reg-cta}}

Who Can File an Application under Section 241 of the Companies Act, 2013?

Eligibility to file under Section 241 depends on the applicant’s status and shareholding:

In addition, the Central Government can also apply under Section 241(2) if it believes the affairs of the company are conducted in a manner prejudicial to public interest.

Frequently Asked Questions